Therapeutic Gene Editing Safety and Specificity
- PMID: 28895847
- PMCID: PMC5653273
- DOI: 10.1016/j.hoc.2017.05.002
Therapeutic Gene Editing Safety and Specificity
Abstract
Therapeutic gene editing is significant for medical advancement. Safety is intricately linked to the specificity of the editing tools used to cut at precise genomic targets. Improvements can be achieved by thoughtful design of nucleases and repair templates, analysis of off-target editing, and careful utilization of viral vectors. Advancements in DNA repair mechanisms and development of new generations of tools improve targeting of specific sequences while minimizing risks. It is important to plot a safe course for future clinical trials. This article reviews safety and specificity for therapeutic gene editing to spur dialogue and advancement.
Keywords: Gene editing; Gene therapy; Off-target; Safety; Specific.
Copyright © 2017 Elsevier Inc. All rights reserved.
References
-
- Blaese RM, Culver KW, Miller AD, et al. T Lymphocyte-Directed Gene Therapy for ADA− SCID: IniLal Trial Results After 4 Years. Science. 1995;270(5235):475–480. - PubMed
-
-
Optimized CRISPR Design
-
-
- Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990;249(4968):505–510. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
